Figure 2.
Figure 2. Detection of antibodies against rhEPO in sera of cynomolgus macaques treated with pseudotyped AAV2CMVrhEPO vector. The animals in Figure 1 that developed anemia were evaluated for rhEPO antibodies. (A) AAV2/1, 17108. (B) AAV2/5, 17111. (C) AAV2/5, 17112. (D) AAV2/8, 17148. Growth inhibition of the EPO-dependent cell line HCD57 in the presence of a constant dilution of macaque serum is represented on the right y-axis (solid lines, ▪) as cell viability measured by cell proliferation assay. Binding of antibody to EPO and interference of its detection is illustrated on the left y-axis (dotted lines, □) as percentage of EPO detected in the presence of antisera in comparison with that detected in the standard EPO assay. Ten-fold diluted antisera were used for both assays. The impact of sera on these assays, drawn at different times following vector, are shown.

Detection of antibodies against rhEPO in sera of cynomolgus macaques treated with pseudotyped AAV2CMVrhEPO vector. The animals in Figure 1 that developed anemia were evaluated for rhEPO antibodies. (A) AAV2/1, 17108. (B) AAV2/5, 17111. (C) AAV2/5, 17112. (D) AAV2/8, 17148. Growth inhibition of the EPO-dependent cell line HCD57 in the presence of a constant dilution of macaque serum is represented on the right y-axis (solid lines, ▪) as cell viability measured by cell proliferation assay. Binding of antibody to EPO and interference of its detection is illustrated on the left y-axis (dotted lines, □) as percentage of EPO detected in the presence of antisera in comparison with that detected in the standard EPO assay. Ten-fold diluted antisera were used for both assays. The impact of sera on these assays, drawn at different times following vector, are shown.

Close Modal

or Create an Account

Close Modal
Close Modal